Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Radiology|March 18, 2023
Optimized radiological alert thresholds based on device-dosimetric information to predict peak skin dose between 2 and 4 Gy during vascular fluoroscopically guided interventionNicolas Sas, Jean-Baptiste Lacroix, Véronique Dedieu, et al.
European Radiology|November 6, 2020
Optimized radiological alert thresholds based on device dosimetric information and peak skin dose in vascular fluoroscopically guided interventionNicolas Sas, Florian Magnier, Eléonore Pouget, et al.
EJNMMI Physics|October 24, 2024
360° CZT-SPECT/CT cameras: <sup>99m</sup>Tc- and <sup>177</sup>Lu-phantom-based evaluation under clinical conditionsChristopher Hoog, Pierre-Malick Koulibaly, Nicolas Sas, et al.
Medical Physics|November 20, 2020
Internal dosimetry of [<sup>99m</sup> Tc]NTP15-5 radiotracer for cartilage imaging in preclinical and clinical models using the GATE Monte Carlo platformGiovanna Rosa Fois, Clémence Valla, Elodie Jouberton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2014
A compartmental model of mouse thrombopoiesis and erythropoiesis to predict bone marrow toxicity after internal irradiationNicolas Sas, Julie Rousseau, Frédérique Nguyen, et al.
EJNMMI Research|May 25, 2023
Imaging quality of an artificial intelligence denoising algorithm: validation in <sup>68</sup>Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancerCharles Margail, Charles Merlin, Tommy Billoux, et al.
Andrology|January 28, 2026
Effects of Low-to-Moderate Ionizing Radiation on Human Sperm Function and DNA IntegrityOriana Carcy, Nicolas Sas, Marion Chanchou, et al.
EJNMMI Research|September 26, 2025
[<sup>99m</sup>Tc]Tc-NTP 15 - 5, a new proteoglycan tracer for functional imaging of joint cartilage: phase I (CARSPECT)Marion Chanchou, Emilie Thivat, Sylvain Mathieu, et al.
EJNMMI Research|September 26, 2025
Tumor sink effect on melanin-ligand [<sup>131</sup>I]ICF01012 in melanoma and its implications for targeted radionuclide therapyElodie Jouberton, Sophie Besse, Tommy Billoux, et al.
BMC Cancer|April 16, 2022
Phase I study of [<sup>131</sup>I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocolEmilie Thivat, Jacques Rouanet, Philippe Auzeloux, et al.
Pageof 2